Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM63873
Volume:
10 |
5 |
May 2026
Pages:
1-14
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Department of Pharmaceutics
Shram Sadhana Bombay Trust's Institute Of Pharmacy
Cancer remains one of the leading causes of mortality worldwide, creating a continuous demand for novel and effective therapeutic agents with improved selectivity and reduced adverse effects. Natural bioactive compounds derived from animal venoms have recently gained significant attention in biomedical research due to their diverse pharmacological activities. Among them, scorpion venom represents a rich source of biologically active peptides, enzymes, and low-molecular-weight compounds with promising anticancer potential. The present review focuses on the phytochemical and biochemical characterization of scorpion venom components and their cytotoxic effects against various cancer cell lines. Scorpion venom contains numerous ion channel-modulating peptides, antimicrobial peptides, neurotoxins, and non-disulfide bridged peptides that exhibit selective activity against malignant cells. Several experimental studies have demonstrated that these venom-derived molecules can inhibit tumor cell proliferation, induce apoptosis, arrest the cell cycle, suppress angiogenesis, and reduce metastasis in cancers such as breast cancer, glioma, leukemia, lung carcinoma, prostate cancer, cervical cancer, and colorectal cancer. The anticancer activity of scorpion venom is mainly associated with modulation of sodium, potassium, calcium, and chloride ion channels, along with activation of mitochondrial apoptotic pathways involving caspases, p53, Bax, and Fas-mediated signaling. In addition to cytotoxicity, certain venom peptides possess tumor-targeting abilities, making them valuable candidates for drug delivery systems and targeted cancer therapy. Components such as chlorotoxin, bengalin, neopladine, and BmKn-2 have shown remarkable therapeutic potential in preclinical investigations. Despite these promising findings, clinical application remains limited due to challenges including venom toxicity, poor selectivity toward healthy tissues, dosage standardization, and large-scale purification of bioactive compounds. Overall, scorpion venom and its isolated components represent a promising frontier in anticancer drug discovery. Further research involving structural modification, molecular characterization, toxicity profiling, and clinical evaluation may contribute to the development of safer and more effective venom-based anticancer therapeutics in the future.
KEYWORDS
The present study highlights the significant anticancer potential of scorpion venom and its bioactive components. Phytochemical and biochemical characterization confirmed the presence of biologically active peptides, neurotoxins, chlorotoxins, and ion channel-modulating compounds that contribute to its cytotoxic activity against cancer cells. The venom demonstrated concentration-dependent inhibition of cancer cell viability, indicating strong cytotoxic and antiproliferative properties. The observed anticancer effects were mainly associated with apoptosis induction, mitochondrial membrane disruption, cell cycle arrest, inhibition of angiogenesis, and suppression of tumor invasion and metastasis. These mechanisms collectively support the therapeutic value of scorpion venom-derived peptides in cancer treatment. The study also revealed that venom peptides possess selective interactions with cancer-associated ion channels and signaling pathways, making them promising candidates for targeted anticancer therapy. Comparison with previously reported literature further confirmed the effectiveness of scorpion venom against various cancer cell lines including breast cancer, colorectal cancer, lung cancer, prostate cancer, and cervical cancer. Although further investigation is necessary to ensure safety and clinical applicability, the present findings suggest that scorpion venom represents a valuable natural source of novel anticancer compounds with considerable pharmaceutical potential.
[1] Ochoa JA, Rojas Runjaic FJM. Scorpions. In: Biodiversity of Pantepui. Elsevier; 2019. p. 223–246. [2] Attarde SS, Pandit SV. Scorpion venom as therapeutic agent: current perspective. J Curr Pharm Res. 2016;7:59–72. [3] Del Brutto O. H. (2013). Neurological effects of venomous bites and stings: snakes, spiders, and scorpions. Handbook of clinical neurology, 114, 349–368. https://doi.org/10.1016/B978-0-444-53490-3.00028-5 [4] Corona, M., Coronas, F. V., Merino, E., Becerril, B., Gutiérrez, R., Rebolledo-Antunez, S., Garcia, D. E., & Possani, L. D. (2003). A novel class of peptide found in scorpion venom with neurodepressant effects in peripheral and central nervous system of the rat. Biochimica et biophysica acta, 1649(1), 58–67. https://doi.org/10.1016/s1570-9639(03)00155-9 [5] Wang, R., Moreau, P., Deschamps, A., de Champlain, J., Sauvé, R., Foucart, S., Bai, L., & Lu, X. R. (1994). Cardiovascular effects of Buthus martensii (Karsch) scorpion venom. Toxicon : official journal of the International Society on Toxinology, 32(2), 191–200. https://doi.org/10.1016/0041-0101(94)90108-2 [6] Tong-ngam, P., Roytrakul, S., & Sritanaudomchai, H. (2015). BmKn-2 scorpion venom peptide for killing oral cancer cells by apoptosis. Asian Pacific journal of cancer prevention : APJCP, 16(7), 2807–2811. https://doi.org/10.7314/apjcp.2015.16.7.2807 [7] Roger, S., Rollin, J., Barascu, A., Besson, P., Raynal, P. I., Iochmann, S., Lei, M., Bougnoux, P., Gruel, Y., & Le Guennec, J. Y. (2007). Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines. The international journal of biochemistry & cell biology, 39(4), 774–786. https://doi.org/10.1016/j.biocel.2006.12.007 [8] Béchohra, L., Laraba-Djebari, F., & Hammoudi-Triki, D. (2016). Cytotoxic activity of Androctonus australis hector venom and its toxic fractions on human lung cancer cell line. The journal of venomous animals and toxins including tropical diseases, 22, 29. https://doi.org/10.1186/s40409-016-0085-4 [9] Diss, J. K., Stewart, D., Pani, F., Foster, C. S., Walker, M. M., Patel, A., & Djamgoz, M. B. (2005). A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate cancer and prostatic diseases, 8(3), 266–273. https://doi.org/10.1038/sj.pcan.4500796 [10] Dardevet, L., Rani, D., Aziz, T. A., Bazin, I., Sabatier, J. M., Fadl, M., Brambilla, E., & De Waard, M. (2015). Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion. Toxins, 7(4), 1079–1101. https://doi.org/10.3390/toxins7041079
Publication Date
5/24/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
0
Total views since publication
PDF Downloads
2
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...